- abnormal snout morphology / IMPC
- decreased circulating fructosamine level / IMPC
- improved glucose tolerance / IMPC
- decreased mean platelet volume / IMPC
- increased circulating alkaline phosphatase level / IMPC
- prolonged QRS complex duration / IMPC
- abnormal gait / IMPC
- decreased startle reflex / IMPC
- decreased body weight / IMPC
- decreased total body fat amount / IMPC
- increased lean body mass / IMPC
- decreased body length / IMPC
- decreased exploration in new environment / IMPC
- decreased circulating glucose level / IMPC
- decreased lean body mass / IMPC
B6Dnk;B6N-Gsk3atm1a(EUCOMM)Hmgu/Ieg
Status | Available to order |
EMMA ID | EM:04745 |
International strain name | B6Dnk;B6N-Gsk3atm1a(EUCOMM)Hmgu/Ieg |
Alternative name | HEPD0506_1_B11 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Gsk3atm1a(EUCOMM)Hmgu |
Gene/Transgene symbol | Gsk3a |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Provider affiliation | Institute of Experimental Genetics, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Genetic information | This mouse line originates from EUCOMM ES clone HEPD0506_1_B11. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Animals used for archiving | heterozygous C57BL/6Dnk, wild-type C57BL/6Dnk |
Stage of embryos | 2-cell |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- decreased body length / MGI
- decreased body weight / MGI
- no abnormal phenotype detected / MGI
- increased insulin sensitivity / MGI
- no phenotypic analysis / MGI
- decreased circulating glycerol level / MGI
- increased lean body mass / MGI
- decreased lumbar vertebrae number / MGI
- improved glucose tolerance / MGI
- homeostasis/metabolism phenotype / MGI
- craniofacial phenotype / MGI
- decreased percent body fat/body weight / MGI
- decreased circulating glucose level / MGI
- decreased total body fat amount / MGI
- increased sacral vertebrae number / MGI
- increased liver glycogen level / MGI
- wide metopic suture / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).